Complicated skin and soft tissue infection (Q37793714)

23 August 2017

title

Complicated skin and soft tissue infection (English)

1 reference

23 August 2017

Matthew S. Dryden

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20876627

22 July 2024

language of work or name

English

0 references

publication date

1 November 2010

1 reference

full work available at URL

23 August 2017

published in

Journal of Antimicrobial Chemotherapy

1 reference

23 August 2017

volume

65 Suppl 3

1 reference

23 August 2017

page(s)

iii35-44

1 reference

Complicated infections of skin and skin structures: when the infection is more than skin deep

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Practice guidelines for the diagnosis and management of skin and soft-tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

“Celbenin” - resistant Staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Methicillin-resistant Staphylococcus aureus: implications for the 1990s and effective control measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Three-year surveillance of community-acquired Staphylococcus aureus infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

MRSA carriage in healthcare personnel in contact with farm animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Increasing incidence of methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: reconsideration of empiric antimicrobial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Use of the bacteriology laboratory to decrease general practitioners' antibiotic prescribing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Necrotizing fasciitis: case report and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Emerging role of the interleukin-8 cleaving enzyme SpyCEP in clinical Streptococcus pyogenes infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

High diversity of Panton-Valentine leukocidin-positive, methicillin-susceptible isolates of Staphylococcus aureus and implications for the evolution of community-associated methicillin-resistant S. aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Effect of antibiotics on Staphylococcus aureus producing Panton-Valentine leukocidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Superantigens and streptococcal toxic shock syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Clinical Presentation and Bacteriologic Analysis of Infected Human Bites in Patients Presenting to Emergency Departments

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Hospitalization due to Pasteurella multocida-infected animal bite wounds: correlation with inadequate primary antibiotic medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Management of fever in patients with cancer and treatment-induced neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Trimethoprim-sulfamethoxazole or clindamycin for treatment of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Linezolid versus glycopeptide or beta-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Sequential intravenous/oral moxifloxacin versus intravenous piperacillin-tazobactam followed by oral amoxicillin-clavulanate for the treatment of complicated skin and skin structure infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

In vitro activities of moxifloxacin against 900 aerobic and anaerobic surgical isolates from patients with intra-abdominal and diabetic foot infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

International Journal of Antimicrobial Agents

21 January 2018

1

33

: 2

2009

1 reference

Clostridium difficile in food--innocent bystander or serious threat?

22 July 2024

2

1 reference

Managing skin and soft tissue infections: expert panel recommendations on key decision points

22 July 2024

5

1 reference

Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock

22 July 2024

6

1 reference

Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surve

22 July 2024

7

1 reference

Journal of Drugs in Dermatology

22 July 2024

12

7

751

Bruce

2008

1 reference

Complicated skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus: epidemiology, risk factors, and presentation

22 July 2024

13

1 reference

An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients

22 July 2024

16

1 reference

Early appropriate parenteral antimicrobial treatment of complicated skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus

22 July 2024

18

1 reference

Emergence of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) in Southeast Austria

22 July 2024

22

1 reference

22 July 2024

23

14

1

2009

1 reference

Nosocomial transmission of community-associated methicillin-resistant Staphylococcus aureus: an emerging threat

22 July 2024

25

1 reference

Pasteurella multocida from a dog causing Ludwig's angina

22 July 2024

30

1 reference

Pathogenic role of Bacillus cereus in wound infections in the tropics

22 July 2024

31

1 reference

Comment on: Antibiotic stewardship--more education and regulation not more availability?

22 July 2024

33

1 reference

Pathogenesis of methicillin-resistant Staphylococcus aureus infection

22 July 2024

37

1 reference

Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus

22 July 2024

40

1 reference

Aeromonas hydrophila soft-tissue infection as a complication of snake bite: report of three cases

22 July 2024

44

1 reference

22 July 2024

Caiman bite

45

1 reference

22 July 2024

Dog bites

47

1 reference

The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam

22 July 2024

61

1 reference

Treatment of complicated skin and soft tissue infections

22 July 2024

63

1 reference

Journal of Antimicrobial Chemotherapy

22 July 2024

64

62

7

2008

1 reference

Are the new quinolones appropriate treatment for community-acquired methicillin-resistant Staphylococcus aureus?

22 July 2024

70

1 reference

22 July 2024

Identifiers

DOI

10.1093/JAC/DKQ302

1 reference

23 August 2017

1 reference